Speech disturbances in patients with dystonia or chorea due to neurometabolic disorders

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1605-1611

  Flamand Rouvière, Constance ^a   Guettard, Emilie ^b   Moreau, Caroline ^c   Bahi Buisson, Nadia ^d,e   Valayannopoulos, Vassili ^d   Grabli, David ^f   Motte, Jacques ^g   Rodriguez, Diana ^h   Roubertie, Agathe ⁱ   Maintigneux, Lisa ^a   Kemlin, Isabelle ^h   Ceballos Picot, Irène ^d   Adams, David ^a   Vidailhet, Marie ^f   Roze, Emmanuel ^e,f,j,k  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c IFR 114   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Groupe Hospitalier Pitié Salpêtrière ^*  (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g AMERICAN MEMORIAL HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ MONTPELLIER UNIVERSITY HOSPITAL   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k CNRS   (France)

more..

Author keywords

Dystonia; Glutaric aciduria type 1; GM1 gangliosidosis type 3; Hyperkinetic dysarthria; Lesch Nyhan disease; Speech apraxia

Indexed keywords

ADOLESCENT; ADULT; APRAXIA; ARTICLE; CHILD; CHOREA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE SEVERITY; DYSARTHRIA; DYSTONIA; DYSTONIA OR CHOREA DUE TO NEUROMETABOLIC DISORDER; FEMALE; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; MALE; METABOLIC DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCHOOL CHILD; SPEECH DISORDER; SPEECH INTELLIGIBILITY; SPEECH REHABILITATION;

ADOLESCENT; ADULT; BRAIN DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; CHOREA; DYSTONIA; FAMILY HEALTH; FEMALE; HUMANS; MALE; NEUROLOGIC EXAMINATION; SPEECH DISORDERS; YOUNG ADULT;

EID: 77955798406     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23134     Document Type: Article

References (35)

1. Roze E, Paschke E, Lopez N, et al. Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 2005;20:1366-1369.
2. Gitiaux C, Roze E, Kinugawa K, et al. Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 2008;23:2392-2397.
3. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006;129:1201-1217.
4. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 2003;121:38-52.
5. Kyllerman M, Skjeldal OH, Lundberg M, et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord 1994;9:22-30.
6. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-223.
7. Raven JC, Court JH, Raven J, editors. Raven manual: advanced progressive matrices, UK: Oxford Psychologist Press Ltd; 1998.
8. Auzou P, Ozsancak C, Jan M, et al. [Clinical assessment of dysarthria: presentation and validation of a method]. Rev Neurol (Paris) 1998;154:523-530.
9. Enderby P, editor. Frenchay dysarthria assessment, San Diego: College-Hill Press; 1983.
10. Wertz RT, Lapointe LL, Rosenbek JC, editors. Apraxia of Speech in Adults: The Disorder and Its Management, Orlando: Grune and Stratton; 1984.
11. Crochemore E, Amossé C. Apraxie de la parole. In: Auzou P, Ozsancak C, Brun V, editors. les dysarthries, Paris: Masson; 2001. p 217-229.
12. Duffy JR. Hyperkinetic dysarthrias. In: Duffy JR, editor. Motor speech disorders: substrates, differential diagnosis and management, Second ed. Saint Louis: Elsevier Mosby; 2005. p 217-253.
13. Duffy JR. Apraxia of speech. In: Duffy JR, editor. Motor spech disorders: substrates, differential diagnosis and management, Second ed. Saint Louis: Elsevier Mosby; 2005. p 307-334.
14. Darley FL, Aronson AE, Brown JR. Motor speech disorders, Philadelphia: Saunders; 1975.
15. Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 2008;21:688-692.
16. Wambaugh JL. A summary of treatments for apraxia of speech and review of replicated approaches. Semin Speech Lang 2002;23:293-308.
17. Hayden DA, Square PA. Motor speech treatment hierarchy: a systems approach. Clin Commun Disord 1994;4:162-174.
18. Yorkston KM, Beuckelman DR, Strand EA, Bell KR. Management of motor speech disorders in children and adults, Austin: Pro-Ed; 1999.
19. Johnston MV. Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev 2009;15:94-101.
20. Holloway V, Gadian DG, Vargha-Khadem F, Porter DA, Boyd SG, Connelly A. The reorganization of sensorimotor function in children after hemispherectomy. A functional MRI and somatosensory evoked potential study. Brain 2000;123: 2432-2444.
21. Anderson V, Spencer-Smith M, Leventer R, et al. Childhood brain insult: can age at insult help us predict outcome? Brain 2009;132:45-56.
22. Anderson V, Catroppa C, Morse S, Haritou F, Rosenfeld J. Functional plasticity or vulnerability after early brain injury? Pediatrics 2005;116:1374-1382.
23. Chen CC, Heinemann AW, Bode RK, Granger CV, Mallinson T. Impact of pediatric rehabilitation services on children's functional outcomes. Am J Occup Ther 2004;58:44-53.
24. Horster F, Hoffmann GF. Pathophysiology, diagnosis, and treatment of methylmalonic aciduria-recent advances and new challenges. Pediatr Nephrol (Berlin, Germany) 2004;19:1071-1074.
25. Duffy JR. Neurologic basis of moor speech and its pathologies. In: Duffy JR, editor. Motor speech disorders: substrates, differential diagnosis and management, Second ed. Saint Louis: Elsevier Mosby; 2005. p 53-54.
26. Alexander MP, Naeser MA, Palumbo CL. Correlations of subcortical CT lesion sites and aphasia profiles. Brain 1987;110:961-991.
27. Peach RK, Tonkovich JD. Phonemic characteristics of apraxia of speech resulting from subcortical hemorrhage. J Commun Disord 2004;37:77-90.
28. Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000;54:458-462.
29. Goberman A, Coelho C, Robb M. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states. J Commun Disord 2002;35:217-239.
30. Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov Disord 2008;23:574-580.
31. De Letter M, Santens P, Van Borsel J. The effects of levodopa on word intelligibility in Parkinson's disease. J Commun Disord 2005;38:187-196.
32. Skodda S, Rinsche H, Schlegel U. Progression of dysprosody in Parkinson's disease over time - a longitudinal study. Mov Disord 2009;24:716-722.
33. Kanovsky P. Dystonia: a disorder of motor programming or motor execution? Mov Disord 2002;17:1143-1147.
34. Hamano T, Kaji R, Katayama M, et al. Abnormal contingent negative variation in writer's cramp. Clin Neurophysiol 1999;110:508-515.
35. Vidailhet M, Grabli D, Roze E. Pathophysiology of dystonia. Curr Opin Neurol 2009;22:406-413.